AU Patent

AU2017324406A1 — Tesofensine compositions

Assigned to Saniona AS · Expires 2019-05-02 · 7y expired

What this patent protects

The present invention relates to tesofensine compositions, methods to prepare the same and uses thereof in preparing medicines for the prevention and treatment of overweight, obesity and type 2 diabetes mellitus.

USPTO Abstract

The present invention relates to tesofensine compositions, methods to prepare the same and uses thereof in preparing medicines for the prevention and treatment of overweight, obesity and type 2 diabetes mellitus.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017324406A1
Jurisdiction
AU
Classification
—
Expires
2019-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Saniona AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.